These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme. Dorai T, Kobayashi H, Holland JF, Ohnuma T. Mol Pharmacol; 1994 Sep; 46(3):437-44. PubMed ID: 7935323 [Abstract] [Full Text] [Related]
3. Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling. Matsui T, Sano K, Tsukamoto T, Ito M, Takaishi T, Nakata H, Nakamura H, Chihara K. J Clin Invest; 1993 Sep; 92(3):1153-60. PubMed ID: 8376577 [Abstract] [Full Text] [Related]
4. Effect of PDGF, IL-1alpha, and BMP2/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea. Kim WJ, Mohan RR, Mohan RR, Wilson SE. Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1364-72. PubMed ID: 10359318 [Abstract] [Full Text] [Related]
5. Coexpression of tumor-associated alpha 2-macroglobulin and growth factors in human melanoma cell lines. Lizonová A, Bízik J, Grófóva M, Vaheri A. J Cell Biochem; 1990 Aug; 43(4):315-25. PubMed ID: 1697862 [Abstract] [Full Text] [Related]
6. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. Schadendorf D, Möller A, Algermissen B, Worm M, Sticherling M, Czarnetzki BM. J Immunol; 1993 Sep 01; 151(5):2667-75. PubMed ID: 8360485 [Abstract] [Full Text] [Related]
7. Human keratinocytes are a major source of cutaneous platelet-derived growth factor. Ansel JC, Tiesman JP, Olerud JE, Krueger JG, Krane JF, Tara DC, Shipley GD, Gilbertson D, Usui ML, Hart CE. J Clin Invest; 1993 Aug 01; 92(2):671-8. PubMed ID: 8349805 [Abstract] [Full Text] [Related]
8. Growth factor modulation of melanoma growth stimulatory activity mRNA expression in human malignant melanoma cells correlates with cell growth. Bordoni R, Thomas G, Richmond A. J Cell Biochem; 1989 Apr 01; 39(4):421-8. PubMed ID: 2722970 [Abstract] [Full Text] [Related]
9. IL-1 and transforming growth factor-beta inhibit platelet-derived growth factor-AA binding to osteoblastic cells by reducing platelet-derived growth factor-alpha receptor expression. Yeh YL, Kang YM, Chaibi MS, Xie JF, Graves DT. J Immunol; 1993 Jun 15; 150(12):5625-32. PubMed ID: 8515080 [Abstract] [Full Text] [Related]
10. Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: an immunohistochemical and in situ hybridization study. Wang J, Coltrera MD, Gown AM. Cancer Res; 1994 Jan 15; 54(2):560-4. PubMed ID: 7903911 [Abstract] [Full Text] [Related]
11. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression. Hung WC, Huang JS, Chuang LY. Biochem Biophys Res Commun; 1996 Mar 27; 220(3):719-23. PubMed ID: 8607831 [Abstract] [Full Text] [Related]
12. Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells. DiPaola RS, Kuczynski WI, Onodera K, Ratajczak MZ, Hijiya N, Moore J, Gewirtz AM. Cancer Gene Ther; 1997 Mar 27; 4(3):176-82. PubMed ID: 9171936 [Abstract] [Full Text] [Related]
13. Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo. Langerak AW, De Laat PA, Van Der Linden-Van Beurden CA, Delahaye M, Van Der Kwast TH, Hoogsteden HC, Benner R, Versnel MA. J Pathol; 1996 Feb 27; 178(2):151-60. PubMed ID: 8683381 [Abstract] [Full Text] [Related]
14. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. Di Paolo S, Gesualdo L, Ranieri E, Grandaliano G, Schena FP. Am J Pathol; 1996 Dec 27; 149(6):2095-106. PubMed ID: 8952542 [Abstract] [Full Text] [Related]
15. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type. Ramp U, Jaquet K, Reinecke P, Schardt C, Friebe U, Nitsch T, Marx N, Gabbert HE, Gerharz CD. J Urol; 1997 Jun 27; 157(6):2345-50. PubMed ID: 9146668 [Abstract] [Full Text] [Related]
16. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Dabrow MB, Francesco MR, McBrearty FX, Caradonna S. Gynecol Oncol; 1998 Oct 27; 71(1):29-37. PubMed ID: 9784315 [Abstract] [Full Text] [Related]
17. Characterization of platelet-derived growth factor (PDGF) action on a mouse neuroblastoma cell line, NB41, by introduction of an antisense PDGF beta-receptor RNA. Funa K, Ahgren A. Cell Growth Differ; 1997 Aug 27; 8(8):861-9. PubMed ID: 9269895 [Abstract] [Full Text] [Related]
18. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene. Yang DC, Jiang XP, Elliott RL, Head JF. Anticancer Res; 2001 Aug 27; 21(3B):1777-87. PubMed ID: 11497259 [Abstract] [Full Text] [Related]
19. Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Gerwin BI, Lechner JF, Reddel RR, Roberts AB, Robbins KC, Gabrielson EW, Harris CC. Cancer Res; 1987 Dec 01; 47(23):6180-4. PubMed ID: 3479241 [Abstract] [Full Text] [Related]
20. Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts. Ylä-Outinen H, Aaltonen V, Björkstrand AS, Hirvonen O, Lakkakorpi J, Vähä-Kreula M, Laato M, Peltonen J. J Invest Dermatol; 1998 Mar 01; 110(3):232-7. PubMed ID: 9506441 [Abstract] [Full Text] [Related] Page: [Next] [New Search]